News
First COVID-19 vaccine shipments arrive in Canada, more en route
Some of the country's initial 30,000 doses of the Pfizer-BioNTech vaccines touched down on Sunday night, Prime Minister Justin Trudeau announced on Twitter, sharing...
Clinical Trials
Novartis provides update on RUXCOVID study of ruxolitinib for hospitalized patients with COVID-19
Novartis announced that the Phase III RUXCOVID study evaluating ruxolitinib on top of standard of care (SoC) therapy compared to SoC treatment alone in...
News
Saudi Arabia approves Pfizer-BioNTech coronavirus vaccine
Saudi Arabia approved the use of the Pfizer-BioNTech novel coronavirus vaccine, state media reported, becoming the second Gulf country after Bahrain to green-light the...
News
ERT and Bioclinica to Merge, Creating a Global Leader in Clinical Trial Endpoint Technology
ERT, a global leader in clinical end-point data solutions, announced that Bioclinica, a technological and scientific leader in clinical imaging, has agreed to merge...
Clinical Trials
Sinovac snags $515M investment to double COVID-19 vaccine capacity as phase 3 readout nears
As the various COVID-19 vaccines move closer to the finish line, their developers have been raising money from investors or through advance government purchases...
News
Sinovac Announces Product License for 23-Valent Pneumococcal Polysaccharide Vaccine
Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced that the China National Medical Products Administration (NMPA) has approved and issued...
News
AstraZeneca and J&J COVID-19 Shots Crucial To Meet US Vaccination Goal
Moncef Slaoui from Operation Warp Speed suggests that AstraZeneca and Johnson & Johnson COVID-19 doses will play a significant role in vaccinating everyone...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read